HIMS & HERS HEALTH INC (HIMS) Stock Price Today & Analysis

Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
About HIMS & HERS HEALTH INC
Hims & Hers Health, Inc. is an American telehealth company founded in 2017 and headquartered in San Francisco, California. The company operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling access to medical care for various conditions related to sexual health, hair care, mental health, skincare, primary care, and more. Hims & Hers Health went public in January 2021 through a merger with a special purpose acquisition company (SPAC), Oaktree Acquisition Corp., achieving a valuation of $1.6 billion. HIMS is under NYSE and has a market capitalization of approximately $6.17 billion. In recent developments, the company announced plans to sell Eli Lilly's weight-loss drug, Zepbound, on its telehealth platform as part of an effort to expand its weight-loss offerings. This move aims to provide customers with access to branded versions of weight-loss medications.
